LUSSO, PAOLO
 Distribuzione geografica
Continente #
EU - Europa 15.690
NA - Nord America 4.931
AS - Asia 1.722
SA - Sud America 228
Continente sconosciuto - Info sul continente non disponibili 46
AF - Africa 29
OC - Oceania 4
Totale 22.650
Nazione #
IT - Italia 14.676
US - Stati Uniti d'America 4.877
SG - Singapore 672
CN - Cina 647
UA - Ucraina 352
SE - Svezia 224
BR - Brasile 176
FI - Finlandia 123
VN - Vietnam 119
DE - Germania 98
GB - Regno Unito 90
FR - Francia 80
IN - India 60
BD - Bangladesh 52
HK - Hong Kong 42
KR - Corea 40
CA - Canada 25
RU - Federazione Russa 22
AR - Argentina 17
TR - Turchia 17
IQ - Iraq 12
MX - Messico 11
CO - Colombia 10
ID - Indonesia 9
EC - Ecuador 8
UZ - Uzbekistan 8
PH - Filippine 7
PK - Pakistan 7
NL - Olanda 6
JM - Giamaica 5
PY - Paraguay 5
SA - Arabia Saudita 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
ES - Italia 4
KE - Kenya 4
MA - Marocco 4
MU - Mauritius 4
VE - Venezuela 4
AU - Australia 3
CL - Cile 3
CR - Costa Rica 3
ET - Etiopia 3
JP - Giappone 3
MY - Malesia 3
NP - Nepal 3
BO - Bolivia 2
DZ - Algeria 2
GT - Guatemala 2
IE - Irlanda 2
IL - Israele 2
KZ - Kazakistan 2
LT - Lituania 2
NI - Nicaragua 2
PL - Polonia 2
RS - Serbia 2
TN - Tunisia 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AZ - Azerbaigian 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
HN - Honduras 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
SN - Senegal 1
SV - El Salvador 1
TG - Togo 1
TT - Trinidad e Tobago 1
VC - Saint Vincent e Grenadine 1
Totale 22.604
Città #
Cagliari 14.343
Woodbridge 538
Fairfield 534
Singapore 362
Houston 346
Ashburn 332
Chandler 315
San Jose 256
Seattle 243
Ann Arbor 224
Cambridge 203
Wilmington 196
Boardman 193
Jacksonville 189
Dallas 167
Nyköping 153
Uta 143
Beijing 134
Los Angeles 89
Council Bluffs 87
Hefei 76
Santa Clara 72
Helsinki 64
Boston 56
Buffalo 56
Nanjing 51
Lauterbourg 45
San Diego 43
Hong Kong 39
Seoul 36
Shanghai 34
Milan 33
Ho Chi Minh City 32
Verona 29
Pune 27
The Dalles 25
Nanchang 23
Columbus 22
Hanoi 22
Hebei 22
Jiaxing 20
New York 20
Changsha 18
Jinan 17
Shenyang 16
Munich 15
Tianjin 15
Sassari 14
Frankfurt am Main 12
Guangzhou 11
London 11
São Paulo 10
Brooklyn 9
Chicago 9
Haiphong 9
Belo Horizonte 8
Norwalk 8
Atlanta 7
Nuremberg 7
San Francisco 7
Tashkent 7
Washington 7
Zhengzhou 7
Delhi 6
Denver 6
Mountain View 6
Ningbo 6
Orange 6
Baghdad 5
Can Tho 5
Dhaka 5
Saint Petersburg 5
Charlotte 4
Goiânia 4
Hangzhou 4
Kingston 4
Montreal 4
Queens 4
Redwood City 4
Rome 4
Salt Lake City 4
Taizhou 4
Toronto 4
Asunción 3
Bangalore 3
Biên Hòa 3
Cincinnati 3
Curitiba 3
Da Nang 3
Dearborn 3
Düsseldorf 3
Erbil 3
Hamburg 3
Johannesburg 3
Kunming 3
Miami 3
Mississauga 3
Nairobi 3
Orem 3
Paris 3
Totale 20.263
Nome #
Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma 1.700
Calibration Technologies for Correct Determination of Epstein-Barr Virus, Human Herpesvirus 6 (HHV-6), and HHV-8 Antiviral Drug Susceptibilities by Use of Real-Time-PCR-Based Assays 611
Chromosomally integrated human herpesvirus 6: questions and answers 593
Tyrosine sulfation in the second variable loop (V2) of HIV-1 gp120 stabilizes V2-V3 interaction and modulates neutralization sensitivity 581
Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor 581
Enhancement of Anti-HIV-1 Activity by Hot Spot Evolution of RANTES-Derived Peptides 575
Glycosylation, Hypogammaglobulinemia, and Resistance to Viral Infections 569
Development of a Human Herpesvirus 6 Species-Specific Immunoblotting Assay 558
Classification of HHV-6A and HHV-6B as distinct viruses 553
A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses 552
Selective Reactivation of Human Herpesvirus 6 in Patients With Autoimmune Connective Tissue Diseases 541
Calibrated real-time polymerase chain reaction for specific quantitation of HHV-6A and HHV-6B in clinical samples 518
The CD8-Derived Chemokine XCL1/Lymphotactin Is a Conformation-Dependent, Broad-Spectrum Inhibitor of HIV-1 505
Treatment with IL-7 Prevents the Decline of Circulating CD4(+) T Cells during the Acute Phase of SIV Infection in Rhesus Macaques 496
HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis 488
Protein-based HIV-1 microbicides. 487
Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4(pos) T cells and macrophages 486
Molecular study of human herpesvirus 6 and 8 involvement in coronary atherosclerosis and coronary instability 486
lmmunomodulation and immunosuppression by human herpesvirus 6A and 6B 476
IL-7 induces expression and activation of integrin alpha 4 beta 7 promoting naive T-cell homing to the intestinal mucosa 429
Inhibition of HIV-1 Infection by Human alpha-Defensin-5, a Natural Antimicrobial Peptide Expressed in the Genital and Intestinal Mucosae 428
The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutants 397
Human herpesvirus 6A accelerates AIDS progression in macaques 365
The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT 355
Evolution of SIV toward RANTES resistance in macaques rapidly progressing to AIDS upon coinfection with HHV-6A 347
Reactivation of human herpesvirus 6 (HHV-6) infection in patients with connective tissue diseases 341
Clinical significance of HIV-1 coreceptor usage 335
Biological and physical characterization of the X4 HIV-1 suppressive factor secreted by LPS-stimulated human macrophages 334
Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoprotein 328
Molecular engineering of RANTES peptide mimetics with potent anti-HIV-1 activity 327
International network for comparison of HIV neutralization assays: the NeutNet report 324
A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load 322
Intraprotomer masking of third variable loop (V3) epitopes by the first and second variable loops (V1V2) within the native HIV-1 envelope glycoprotein trimer 321
A multiplex calibrated real-time PCR assay for quantitation of DNA of EBV-1 and 2 321
Protective versus pathogenic anti-CD4 immunity: insights from the study of natural resistance to HIV infection 320
Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers 318
Rational design of novel HIV-1 entry inhibitors by RANTES engineering 314
Broad-Spectrum Inhibition of HIV-1 by a Monoclonal Antibody Directed against a gp120-Induced Epitope of CD4 309
Identification of RANTES MIP-1 alpha and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells 303
HHV-6 and CMV pneumonitis in immunocompromised patients 285
Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains 283
Infection of natural killer cells by human herpesvirus 6 271
Selective suppression of IL-12 production by human herpesvirus 6 269
: Alpha-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4 265
CD46 is a cellular receptor for human herpesvirus 6 262
A relapsing inflammatory syndrome and active human herpesvirus 8 infection 262
Nef-specific CD45RA+ CD8+ T cells secreting MIP-1beta but not IFN-gamma are associated with nonprogressive HIV-1 infection 256
Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals 254
HHV-6 and the immune system: mechanisms of immunomodulation and viral escape 253
HIV and the chemokine system 250
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression 249
Enhancement of the HIV-1 inhibitory activity of RANTES by modification of the N-terminal region: dissociation from CCR5 activation 245
A rationally designed CD4 mimic inhibits HIV-1 entry and exposes cryptic neutralization epitopes 233
Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6 227
HIV and chemokines: Implications for therapy and vaccines 204
Critical role of the N-loop and beta1-strand hydrophobic clusters of RANTES-derived peptides in anti-HIV activity 195
Structural determinants of HIV-1 blockade and CCR5 recognition in RANTES 193
Totale 22.650
Categoria #
all - tutte 47.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.448


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022482 0 0 39 19 36 15 44 29 64 42 94 100
2022/20231.191 130 115 112 97 101 175 46 127 126 37 55 70
2023/20241.601 120 47 72 172 143 143 86 110 82 329 131 166
2024/20251.476 101 101 243 93 160 129 88 60 125 95 131 150
2025/20262.093 148 135 342 148 147 183 320 69 158 203 178 62
2026/2027228 35 83 110 0 0 0 0 0 0 0 0 0
Totale 22.650